MedTrace Logo

A Study of HCC High Risk Group Using Two Surveillance Tools

NCT02675920 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 139

Last updated 2020-10-08

No results posted yet for this study

Summary

The purpose of this study is to compare sensitivity for hepatocellular carcinoma (HCC) of bi-annual ultrasonography and low dose computed tomography (LDCT) in patients at high risk of HCC.

Conditions

Interventions

DRUG

non-ionic monomer iodinated CT contrast media

patients underwent contrast-enhanced CT using aforementioned CT contrast media (non-ionic monomer iodinated CT contrast media)

Sponsors & Collaborators

  • Taejoon Pharmaceutical Co., Ltd.

    collaborator INDUSTRY

  • Reyon Pharmaceutical Co., Ltd.

    collaborator INDUSTRY

  • Seoul National University Hospital

    lead OTHER

Principal Investigators

  • Jeong Min Lee, MD · Seoul National University Hospital

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-11-28
Primary Completion
2019-01-11
Completion
2019-10-01

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02675920 on ClinicalTrials.gov